Skip to main content

Monsanto Licenses Resolver Expression Analysis System from Rosetta

NEW YORK, June 27 - Monsanto has licensed the Rosetta Resolver gene expression data analysis system from Rosetta Inpharmatics, Rosetta said Wednesday. 

Financial details of the transaction were not disclosed. The Resolver system, Rosetta's flagship product, is exclusively distributed by Agilent Technologies, based in Palo Alto, Calif.

In May, Merck acquired Rosetta for $620 million in stock, but said that Rosetta would continue to operate the Resolver business as a separate cost center. Rosetta has licensed its Resolver system to a number of pharmaceutical and biotechnology companies, including GlaxoSmithKline, Biogen, Immunex, Paradigm Genetics, and Merck.

The Resolver system accepts data from a wide variety of expression profiling formats, including Affymetrix GeneChip and Agilent DNA microarrays, and applies proprietary error models to calculate statistics on the gene expression data. Rosetta, based in Kirkland, Wash., released version 2.0 of the system in the first quarter of 2001.

"The Rosetta Resolver system, which will empower us to conduct thorough and rapid analysis of our gene expression data, has comprehensive features and high quality statistics that can help us to quickly and efficiently develop products and solutions to achieve our goal," said Christine Karslake, director of business development for Monsanto, in a statement.  
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.